30 October 2020

Cancer survival in England for patients diagnosed between 2014 and 2018, and followed up until 2019

Cancer survival in England for patients diagnosed between 2014 and 2018, and followed up until 2019
PHE 30 October 2020
  • Cancer survival statistics for adults and children by stage at diagnosis and by different geographical variations.
  • Main points
    • Melanoma of the skin had the highest age-standardised net survival for 1-year in both males (97.6%) and females (98.8%) and for 5-year in males (90.1%) and females (94.5%) for diagnoses between 2014 and 2018.
    • Pancreatic cancer had the lowest age-standardised net survival for 1-year in males (25.3%) and females (26.6%), and for 5-year in females (8.2%) for diagnoses between 2014 and 2018. For males, the lowest 5-year survival is in mesothelioma cancer (6.7%).
    • We provide survival by stage estimates for 23 cancer sites. Stage data is complete for 86.8% of diagnoses in 2014 to 2018.
    • Childhood cancer survival has continued to improve for 1-, 5- and 10-years, with the 5-year survival seeing the greatest improvement over time; an increase of 7.4 percentage points, from 77.2% in 2001 to 84.6% predicted for children diagnosed in 2019.
    • For Cancer Alliances (CAs), the difference between the minimum and maximum 1-year survival estimates varies from 1.5 percentage points for breast cancer (females only) to 13.1 percentage points for brain cancer (all persons).
  • All graphs can be found on the interactive R Shiny App.